Abstract:In this study, we analysed the dynamics of myeloid cells in a myeloid‐specific Tet2‐deficient mouse model after ischaemia‐induced myocardial infarction (MI). We observed a substantial increase of neutrophils in the post‐MI mice, which contributes to adverse outcomes during heart repair. Mechanistically, Tet2‐deficient myeloid cells exhibited increased genome instability, accompanied with augmented activation of the cGAS‐STING pathway. Inhibition of STING resulted in significantly reduced neutrophils in Tet2‐deficient mice after MI to enable reversal of deleterious cardiac outcomes. Therefore, targeting the cGAS‐STING pathway is a viable therapeutic option to reduce the risk of cardiovascular diseases in CH individuals bearing TET2 LOF mutations. Background Myeloid cells play critical roles in the regulation of myocardial injury and repair. Clonal hematopoiesis (CH)‐related mutations in genes, such as Ten‐eleven Translocation 2 (TET2), can impair myeloid cells and are associated with increased risk of cardiovascular disease (CVD). How Tet2 loss‐of‐function (LOF) impacts myeloid cells and disrupts normal myocardial repair remains unclear. Methods We established ischemia‐induced myocardial infarction (MI) in a myeloid‐specific Tet2‐deficient mouse model. The echocardiographic assessment was conducted to evaluate the cardiac function. Histological analysis was performed to evaluate morphological changes in infarcted areas and fibrosis. To monitor the dynamic changes of myeloid cells in cardiac tissues during cardiac remodeling after MI, we performed longitudinal analysis on subsets of myeloid cells using flow cytometry. We performed immunofluorescence (IF) staining to examine the DNA damage and genome instability caused by Tet2 LOF. Gene expression was assessed by real‐time qRT‐PCR. Stimulator of Interferon Genes (STING) pathway activation was assessed using various methods, including Western blotting, flow cytometry, ELISA and IF staining of key signaling proteins involved in this pathway. Additionally, H‐151 was used as a pharmacological tool to antagonize augmented STING activation in the murine MI model. Results We observed a substantial increase of neutrophils in the post‐MI mice, which contributes to adverse outcomes during heart repair. Mechanistically, Tet2‐deficient myeloid cells exhibited increased genome instability, accompanied with augmented activation of the STING pathway. Furthermore, the use of H‐151 a covalent STING binder that targets the cysteine residue at position 91 and functions as a potent STING antagonist, led to a substantial decrease in neutrophil populations in Tet2‐deficient mice following myocardial infarction, thereby reversing adverse cardiac outcomes. Conclusion Our novel findings establish the rationale for targeting the cGAS‐STING pathway as a promising therapeutic strategy to mitigate cardiovascular disease risk in individuals with clonal hematopoiesis harboring TET2 loss‐of‐function mutations. Highlights Myeloid‐specific Tet2 depletion promotes neutrophil expansion upon myocardium infarction (MI); Tet2‐deficient myeloid cells exhibit increased genome instability and cGAS‐STING overactivation; STING antagonist H‐151 treatment reduces neutrophil expansion in Tet2‐deficient mice after MI and mitigates deleterious cardiac outcomes.

Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury.

The Roles of Macrophages in Heart Regeneration and Repair after Injury

Cardiomyocytic Cyclic GMP-AMP Synthase is Critical for the Induction of Experimental Cardiac Graft Rejection.

The cGAS-STING Pathway: A New Therapeutic Target for Ischemia-Reperfusion Injury in Acute Myocardial Infarction?

Cardiomyocytic cGAS is critical for the induction of experimental cardiac graft rejection

Mitochondrial function in macrophages controls cardiac repair after myocardial infarction

Small molecule STING inhibition improves myocardial infarction remodeling

Mtdna Activates Cgas Signaling and Suppresses the YAP-Mediated Endothelial Cell Proliferation Program to Promote Inflammatory Injury

New Insights and Novel Therapeutic Potentials for Macrophages in Myocardial Infarction

ITGAM: A Pivotal Regulator in Macrophage Dynamics and Cardiac Function During Sepsis-Induced Cardiomyopathy

The cGAS-STING pathway in cardiovascular diseases: from basic research to clinical perspectives

Macrophage Metabolic Signaling during Ischemic Injury and Cardiac Repair

Cardiac injury activates STING signaling via upregulating SIRT6 in macrophages after myocardial infarction

Macrophages promote the transition from myocardial ischemia reperfusion injury to cardiac fibrosis in mice through GMCSF/CCL2/CCR2 and phenotype switching

Cardiac resident macrophages: key regulatory mediators in the aftermath of myocardial infarction

Cooperative sensing of mitochondrial DNA by ZBP1 and cGAS promotes cardiotoxicity

Abstract OEC102: Unbiased Discovery Of Allograft Inflammatory Factor 1 As A New And Critical Immunometabolic Regulatory Node During Cardiac Injury

Global Characteristics and Dynamics of Single Immune Cells After Myocardial Infarction

Inhibiting the cGAS‐STING pathway in myeloid cells effectively improves myocardial healing related to TET2 deficiency‐induced DNA damage response

Reprogramming macrophage metabolism following myocardial infarction: A neglected piece of a therapeutic opportunity

Abstract 4142627: Cardiac Resident Macrophage Produces Collagen I and Contribute to Vascular Maturation after Myocardial Infarction